Cwm, LLC Voyager Therapeutics, Inc. Transaction History
Cwm, LLC
- $28.4 Billion
- Q2 2025
A detailed history of Cwm, LLC transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 7,163 shares of VYGR stock, worth $23,709. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,163
Previous 10,471
31.59%
Holding current value
$23,709
Previous $35,000
37.14%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VYGR
# of Institutions
120Shares Held
34.8MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$18 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$17.6 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$13 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.6 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.51 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $128M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...